Position in AVXL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$15,262
-$2,829 QoQ
Shares Held
5,893
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#132
of 179 holders
Holding Since
Mar 2025
6 quarters on record
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026N.E.W. Advisory Services LLC holds $146,441 across 14 Biotechnology names. AVXL ranks #3 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
1,667 | $90,918 | |
| 2 | ORMP |
Oramed Pharmaceuticals Inc.
|
3,429 | $16,493 | |
| 3 | AVXL |
Anavex Life Sciences Corp.
This page
|
5,893 | $15,262 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
1,000 | $8,370 | |
| 5 | SEPN |
Septerna, Inc.
|
180 | $6,028 | |
| 6 | INSM |
INSMED Inc
|
17 | $1,812 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3 | $1,490 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
20 | $1,489 |
All Filings in AVXL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,262 | 5,893 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $18,091 | 5,893 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $8,163 | 2,293 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $20,407 | 2,293 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $21,141 | 2,293 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $19,673 | 2,293 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||